Vertex, Inc. (NASDAQ: VERX) announced CEO David DeStefano's retirement and succession plan. Christopher Young chosen as new ...

Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the ...

First, pick your designation of choice. In this case, it’s Google’s Professional Machine Learning Engineer certification. Then look up the exam objectives and make sure they match your career goals ...

Vertex Pharmaceuticals should fare better in a down market than most stocks. The big biotech innovator has tremendous growth prospects. The stock offers an attractive risk-reward proposition. 10 ...

After Maze Therapeutics opted not to participate in the National Advertising Division’s (NAD’s) self-regulatory process for monitoring promotional claims, a case brought by competitor Vertex ...

Vertex Pharmaceuticals stock sold off on two pipeline disappointments. The biotech company continues to grow with promising new drugs on the horizon. Vertex's price looks quite attractive, relative to ...

One of Vertex's pipeline disappointments was that VX-993 didn't meet the primary endpoint in a phase 2 study evaluating the NaV1.8 pain signal inhibitor in treating acute pain following bunionectomy ...

Vertex Pharmaceuticals stock sold off on two pipeline disappointments. The biotech company continues to grow with promising new drugs on the horizon. Vertex's price looks quite attractive, relative to ...

Todrick Hall has spoken publicly about the online clamour around the West End production of Burlesque for the first time. Hall directs and choreographs the production, which earned solid write-ups ...